Necessity of time series analysis and effects of direct-acting antivirals on HCV patients awaiting liver transplantation

被引：0
|
作者：
Liu, Xibei [1 ]
Shen, Jay J. [2 ]
Kim, Sun Jung [3 ]
Lee, Yong-Jae [4 ]
Kwak, Myung [5 ]
Yoo, Ji Won [6 ]
机构：
[1] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA
[2] Univ Nevada, Dept Healthcare Adm & Policy, Las Vegas, NV 89154 USA
[3] Soon Chun Hyang Univ, Dept Hlth Adm & Management, Asan, Chungcheongnam, South Korea
[4] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea
[5] Seoul Med Ctr, Dept Emergency Med, Seoul, South Korea
[6] Univ Nevada, Sch Med, Dept Internal Med, 1701 W Charleston Blvd,230, Las Vegas, NV 89102 USA
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 03期
关键词：
ALLOCATION;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：628 / 629
页数：3
相关论文
共 50 条
  • [21] Reactivation of Occult HBV Infection in Patients Cured of HCV With Direct-Acting Antivirals
    Karen Ma
    Susanne Shokoohi
    Nancy Reau
    Current Treatment Options in Infectious Diseases, 2017, 9 (4) : 380 - 388
  • [22] Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients
    Rice, Donald P.
    Ordoveza, Michelle A.
    Palmer, Ann M.
    Wu, George Y.
    Chirch, Lisa M.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (12): : 1507 - 1511
  • [23] Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients
    Rosanna, Villani
    Francesco, Bellanti
    Francesco, Cavallone
    Giorgia, Di Bello
    Rosanna, Tamborra
    Naik, Bukke Vidyasagar
    Archana, Moola
    Gaetano, Serviddio
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 156 : 200 - 206
  • [24] HCV cure with direct-acting antivirals in HIV/HCV coinfected patients belonging to key populations
    Oprea, Cristiana
    Ianache, Irina
    Costescu, Cristiana
    Piscu, Sebastian
    Vasile, Sorina
    Ene, Luminita
    Radoi, Roxana
    Popa, Ionut
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 326 - 326
  • [25] Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters
    Ferreira, Joana
    Bicho, Manuel
    Serejo, Fatima
    VIRUSES-BASEL, 2024, 16 (03):
  • [26] Impact of HCV Therapy with Direct-Acting Antivirals on Lipid Profiles
    Dharwadkar, Pooja
    Drechsler, Henning
    Kouma, Marcus
    Brown, Geri
    Bedimo, Roger
    HEPATOLOGY, 2016, 64 : 980A - 980A
  • [27] The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals
    Chromy, David
    Bauer, David Jm
    Simbrunner, Benedikt
    Jachs, Mathias
    Hartl, Lukas
    Schwabl, Philipp
    Schwarz, Caroline
    Rieger, Armin
    Grabmeier-Pfistershammer, Katharina
    Mandorfer, Mattias
    Trauner, Michael
    Ferenci, Peter
    Gschwantler, Michael
    Reiberger, Thomas
    JOURNAL OF HEPATOLOGY, 2022, 77 : S555 - S555
  • [28] Letter: HBV/HCV coinfection in the era of direct-acting antivirals
    Hsu, C. -S.
    Wang, P. -C.
    Li, C. -H.
    Lin, H. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (02) : 211 - 211
  • [29] NEW BLACK BOX WARNING FOR DIRECT-ACTING ANTIVIRALS FOR HCV
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2017, 117 (02) : 21 - 21
  • [30] Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C
    Neokosmidis, Georgios
    Protopapas, Adonis A.
    Stogiannou, Dimitrios
    Filippidis, Athanasios
    Tziomalos, Konstantinos
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (01): : 58 - 66
12345